Cargando…
Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study
BACKGROUND: The effectiveness of messenger RNA coronavirus disease 2019 (COVID-19) vaccines in patients with atopic dermatitis (AD) is yet to be delineated. It remains largely unknown how AD-related immunosuppressive medications affect the development of vaccine-induced immunity. OBJECTIVE: We aimed...
Autores principales: | Kridin, Khalaf, Schonmann, Yochai, Onn, Erez, Bitan, Dana Tzur, Weinstein, Orly, Cohen, Arnon D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924351/ https://www.ncbi.nlm.nih.gov/pubmed/35294720 http://dx.doi.org/10.1007/s40257-022-00672-5 |
Ejemplares similares
-
Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment—a population-based cohort study
por: Kridin, Khalaf, et al.
Publicado: (2021) -
Tumor necrosis factor inhibitors are associated with a decreased risk of COVID‐19‐associated hospitalization in patients with psoriasis—A population‐based cohort study
por: Kridin, Khalaf, et al.
Publicado: (2021) -
Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study
por: Kridin, Khalaf, et al.
Publicado: (2021) -
Dipeptidyl-peptidase IV inhibitor (DPP4i) confers increased odds of bullous pemphigoid even years after drug initiation
por: Kridin, Khalaf, et al.
Publicado: (2022) -
COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study
por: Tzur Bitan, Dana, et al.
Publicado: (2021)